Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Qvanteq AG

History from 14 Jul 2016

UID
CHE-114.666.128
Legal form
AG
Canton
ZH
Founded
not in the record
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 328k
82k164k246k328k30 Dec 2019 · CHF 296k9 Dec 2025 · CHF 328k2020202120222023202420252026
  • shares
  • Vorzugsaktien A
  • Vorzugsaktien B
  • Vorzugsaktien C
  • Vorzugsaktien D
  • Vorzugsaktien E

Record

  1. SHAB published 30 Dec 2019 · legal date 13 Dec 2019

    Capital increase

    Not assessed

    Paid in cash and by other means

    Nominal capital
    257’950 → 295’717
    Shares
    257’950 → 295’717
    New shares, % of post-step shares
    12.8% (37’767 new)
    Share classes
    101’666 × CHF 1 · 78’519 × CHF 1 Vorzugsaktien A · 79’431 × CHF 1 Vorzugsaktien B · 24’990 × CHF 1 Vorzugsaktien C · 11’111 × CHF 1 Vorzugsaktien D

    Aktienkapital neu: CHF 295'717.00 [bisher: CHF 257'950.00]. Liberierung Aktienkapital neu: CHF 295'717.00 [bisher: CHF 257'950.00]. Aktien neu: 101'666 Namenaktien zu CHF 1.00, 78'519 Namenaktien zu CHF 1.00 (Vorzugsaktien A), 79'431 Namenaktien zu CHF 1.00 (Vorzugsaktien B), 24'990 Namenaktien zu CHF 1.00 (Vorzugsaktien C) und 11'111 Namenaktien zu CHF 1.00 (Vorzugsaktien D) [bisher: 100'000 Namenaktien zu CHF 1.00, 79'431 Namenaktien zu CHF 1.00 (Vorzugsaktien B) und 78'519 Namenaktien zu CHF 1.00 (Vorzugsaktien A)].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1004794694 ↗

  2. SHAB published 9 Dec 2025 · legal date 1 Dec 2025

    Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    295’717 → 328’099
    Shares
    295’717 → 328’099
    New shares, % of post-step shares
    9.9% (32’382 new)
    Share classes
    106’048 × CHF 1 · 78’519 × CHF 1 Vorzugsaktien A · 79’431 × CHF 1 Vorzugsaktien B · 24’990 × CHF 1 Vorzugsaktien C · 11’111 × CHF 1 Vorzugsaktien D · 28’000 × CHF 1 Vorzugsaktien E

    Aktienkapital neu: CHF 328'099.00 [bisher: CHF 295'717.00]. Liberierung Aktienkapital neu: CHF 328'099.00 [bisher: CHF 295'717.00]. Aktien neu: 106'048 Namenaktien zu CHF 1.00, 78'519 Namenaktien zu CHF 1.00 (Vorzugsaktien A), 79'431 Namenaktien zu CHF 1.00 (Vorzugsaktien B), 24'990 Namenaktien zu CHF 1.00 (Vorzugsaktien C), 11'111 Namenaktien zu CHF 1.00 (Vorzugsaktien D) und 28'000 Namenaktien zu CHF 1.00 (Vorzugsaktien E) [bisher: 24'990 Namenaktien zu CHF 1.00 (Vorzugsaktien C), 79'431 Namenaktien zu CHF 1.00 (Vorzugsaktien B), 11'111 Namenaktien zu CHF 1.00 (Vorzugsaktien D), 78'519 Namenaktien zu CHF 1.00 (Vorzugsaktien A) und 101'666 Namenaktien zu CHF 1.00].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company's purpose describes technology or life-sciences development.+0.5
    • A new class of preferred shares was created.+1.5

    Classifier score 0.93 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006506986 ↗

Published by 8 Oct 2026